A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases. Pfizer’s (PFE) Lipitor is the top selling statin, bringing in $10. According to Reuters, Bristol-Myers Squibb (BMY) Pravachol and Merck (MRK) Zocor are also in this category of drugs.
Lipitor went off-patent last year, opening it to competition from generics, and the market continues to be concerned about what this will do to Pfizer’s long term earnings.
Finding a new market for the drug could work wonders.
Douglas A. McIntyre
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.